- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Fr | ENvue Medical, Inc. - 8-K, Current Report | 5 | SEC Filings | ||
| Do | ENvue unveils robotic-assisted AI feeding tube automation tool | 1 | MassDevice | ||
| Do | ENvue Medical stellt Prototyp für robotergestützte Ernährungssonde vor | 1 | Investing.com Deutsch | ||
| Do | ENvue Medical demonstrates robotic feeding tube prototype | 3 | Investing.com | ||
| Do | ENvue Medical, Inc.: ENvue Medical Unveils Its First Robotic-Assisted, Artificial Intelligence, Feeding Tube Automation Tool | 2 | GlobeNewswire (USA) | ||
| Do | Envue Medical Expands AI Navigation Platform With Robotic Prototype | 1 | Benzinga.com | ||
| 09.06. | ENvue Medical, Inc.: ENvue Medical Launches AI Training Platform Establishing Artificial Intelligence Foundation for Robotic Feeding Tube Navigation | 9 | GlobeNewswire (USA) | ||
| ENVUE MEDICAL Aktie jetzt für 0€ handeln | |||||
| 05.06. | ENvue Medical expands platform to second unit in health system | 4 | Investing.com | ||
| 05.06. | ENvue Medical: Führendes US-Kliniknetzwerk weitet Einsatz der Navigationsplattform aus | 4 | Investing.com Deutsch | ||
| 05.06. | ENvue Medical, Inc.: ENvue Medical Expands into Burn Intensive Care Unit at Major Academic Health Network | 233 | GlobeNewswire (Europe) | TYLER, Texas, June 05, 2026 (GLOBE NEWSWIRE) -- ENvue Medical (NASDAQ: FEED) ("ENvue," "ENvue Medical," or the "Company"), a commercial-stage medical device company focused on real-time guided bedside... ► Artikel lesen | |
| 03.06. | ENvue Medical study shows reduced complications at Inova hospitals | 3 | Investing.com | ||
| 03.06. | ENvue Medical, Inc.: ENvue Medical Announces Publication of Landmark Independent Study Highlighting Significant Safety, Time-, and Cost-Saving Benefits of ENvue Navigation Platform in Multi-Hospital System | 1 | GlobeNewswire (USA) | ||
| 19.05. | ENvue Medical, Inc.: ENvue Medical to Showcase ENvue Navigation Platform at AACN NTI 2026 | 2 | GlobeNewswire (USA) | ||
| 18.05. | ENvue Medical, Inc. - 10-Q, Quarterly Report | 2 | SEC Filings | ||
| 15.05. | ENvue Medical, Inc. - NT 10-Q, Notification of inability to timely file Form 10-Q or 10-QSB | 1 | SEC Filings | ||
| 12.05. | ENvue Medical, Inc.: ENvue Medical Secures Three-Year Contract Renewal at 12-Hospital U.S. Health Network as the ENvue Navigation Platform Becomes Standard of Care | 1 | GlobeNewswire (USA) | ||
| 12.05. | EXCLUSIVE: ENvue Medical Says Health System Renewal Extends Platform Adoption Through 2028 | 1 | Benzinga.com | ||
| 08.05. | ENvue Medical, Inc.: ENvue Medical Adds to Intellectual Property Portfolio by Securing USPTO Notice of Allowance for Ultrasound-Enhanced Cannabinoid Drug Delivery Technology | 1 | GlobeNewswire (USA) | ||
| 07.05. | ENvue Medical, Inc.: ENvue Medical Secures Three-Year Purchasing Agreement Renewal with the Group Purchasing Organization (GPO) for One of the Largest Health Systems in the U.S. Operating Over 90 Hospitals | 373 | GlobeNewswire (Europe) | TYLER, Texas, May 07, 2026 (GLOBE NEWSWIRE) -- ENvue Medical, Inc. (NASDAQ: FEED) ("ENvue," "ENvue Medical" or the "Company"), a commercial-stage medical device company focused on real-time guided... ► Artikel lesen | |
| 07.05. | EXCLUSIVE: ENvue Medical Locks In Multi-Year Access To Large US Nonprofit Hospital System Through 2028 | 2 | Benzinga.com |
1 2 3 Weiter >>
45 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SIEMENS HEALTHINEERS | 34,090 | -0,58 % | JPMORGAN stuft Siemens Healthineers auf 'Overweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat das Kursziel für Siemens Healthineers von 55,80 auf 54,30 Euro gesenkt, aber die Einstufung auf "Overweight" belassen. David Adlington passte seine... ► Artikel lesen | |
| BECTON DICKINSON | 132,65 | +0,53 % | XETR NEW INSTRUMENTS AVAILABLE ON XETRA - 03.07.2026 | Folgende Wertpapiere werden in den Handel an folgenden Handelsplätzen (MIC Code) im Quotation Board an der Frankfurter Wertpapierbörse (FWB) aufgenommen. Die Notierung an anderen Handelsplätzen im Quotation... ► Artikel lesen | |
| NUGEN MEDICAL DEVICES | 0,011 | -9,84 % | NuGen Medical Devices Inc.: NuGen Medical Devices Files Patent for Dual Spring Technology Enhancing Needle-Free Injection Performance | Toronto, Ontario--(Newsfile Corp. - May 28, 2026) - NuGen Medical Devices Inc. (TSXV: NGMD) ("NuGen" or the "Company"), a leader in needle free drug delivery, today announced the filing of a new... ► Artikel lesen | |
| SPINEWAY | 0,130 | +3,17 % | Spineway: First-quarter 2026 revenue | Ecully, April 30, 2026 - 6:00 p.m. First-quarter 2026 revenue High order volumeSlower-than-expected normalization of supply chains2026: growth trajectory confirmed In thousands of euros20262025Change... ► Artikel lesen | |
| ASENSUS SURGICAL | - | - | Karl Storz to fully integrate Asensus, discontinue Senhance, Luna robots | ||
| CO-DIAGNOSTICS | 2,565 | -0,19 % | Co-Diagnostics Completes Clinical and Analytical Studies in Preparation for FDA 510(k) Submission of Upper Respiratory Point-of-Care Test | More than 1,400 patients enrolled across 9 clinical sites; analytical performance testing included 27 individual studies and over 10,000 PCR test cup runs
Analytical... ► Artikel lesen | |
| CYTOSORBENTS | 0,356 | +2,89 % | Cytosorbents Corp: CytoSorbents Reports First Quarter 2026 Financial Results, Recent Business Highlights, and Regulatory Update | PRINCETON, N.J., May 13, 2026 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive... ► Artikel lesen | |
| LIFEWARD | 8,050 | +0,62 % | Lifeward Ltd.: Lifeward Secures Growth Capital to Accelerate Commercial Expansion with Up to $11.2 Million in Strategic Financing | HUDSON, Mass. and YOKNEAM ILLIT, Israel, July 07, 2026 (GLOBE NEWSWIRE) -- Lifeward Ltd. (Nasdaq: LFWD) ("Lifeward" or the "Company"), a diversified biomedical innovation company with a portfolio... ► Artikel lesen | |
| CLOVER HEALTH INVESTMENTS | 4,260 | +0,95 % | Clover Health Investments, Corp.: Clover Health to Report Second Quarter 2026 Financial Results on August 5, 2026 | ||
| FULGENT GENETICS | 17,900 | +0,56 % | Fulgent reports interim data for cancer drug FID-007 trial | ||
| NUWELLIS, INC | 3,220 | 0,00 % | XFRA 22S1: AUSSETZUNG/SUSPENSION | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILNUWELL.INC.NEW26... ► Artikel lesen | |
| LOGICMARK | - | - | EQS-News: Benzinga: From "Text Me When You Get Home" To Always-On Protection: Themes Emerging Across The Evolution Of LogicMark's Aster | EQS-News: Benzinga
/ Key word(s): Healthcare
From "Text Me When You Get Home" To Always-On Protection: Themes Emerging Across The Evolution Of LogicMark's Aster 19.05.2026 / 15:05... ► Artikel lesen | |
| EMBECTA | 2,683 | -1,00 % | Embecta Corp.: embecta appoints Nimish Muzumdar as SVP and President, North America | PARSIPPANY, N.J., June 16, 2026 (GLOBE NEWSWIRE) -- Embecta Corp. ("embecta") (Nasdaq: EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical... ► Artikel lesen | |
| CHECK-CAP | 0,980 | 0,00 % | Humanoid Global meldet Fortschritte von MBody AI bei der kommerziellen Expansion und dem geplanten Unternehmenszusammenschluss mit Check-Cap | Vancouver, BC / 14. Juli 2026 / IRW-Press / Humanoid Global
Holdings Corp. ("Humanoid Global" oder das "Unternehmen")
(CSE:ROBO, FWB:0XM1, OTCQB:RBOHF), ein börsennotierter
Investment-Emittent... ► Artikel lesen | |
| ELECTROCORE | 5,150 | -6,36 % | electroCore, Inc.: electroCore Announces Full Year 2025 Financial Results and Organizational Changes | Record full year 2025 net sales of $32.0, an increase of 27% over $25.2 million for the full year 2024 driven by 25% annual growth in our U.S. prescription business and 97% increase in general wellness... ► Artikel lesen |
Das Unternehmen ENVUE MEDICAL INC kann der Branche Gesundheitswesen zugeordnet werden. Die relative Kursveränderung beträgt aktuell +1,53 % bei einem Aktienkurs von 0,470 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu ENVUE MEDICAL INC finden Sie auf Wallstreet Online.